Results 141 to 150 of about 88,456 (270)

Conditioned suppression and opioid kappa receptor in mice.

, 1986
Toshitaka Nabeshima, Hiroyuki Kamei, Kiyoshi Matsuno, Tsutomu Kameyama   +3 more
openalex   +2 more sources

Cannabinoid and Kappa Opioid Receptors Reduce Potassium K Current via Activation of G_sProteins in Cultured Hippocampal Neurons [PDF]

, 2000
Robert E. Hampson, Jian Mu, Sam A. Deadwyler   +2 more
openalex   +1 more source

Erinacine E as a Kappa Opioid Receptor Agonist and Its New Analogs from a Basidiomycete, Hericium ramosum.

, 1998
Toshiyuki Saito, FUKUMATSU AOKI, Hideo Hirai, TAISUKE INAGAKI, YASUE MATSUNAGA, TATSUO SAKAKIBARA, Shinichi Sakemi, YUMIKO SUZUKI, Shuzo Watanabe, Osamu Suga, Tetsujo Sujaku, Adam A. Smogowicz, S.J. Truesdell, John W. Wong, Atsushi Nagahisa, Yasuhiro Kojima, Nakao Kojima   +16 more
openalex   +2 more sources

Molecular and behavioral mechanisms mediating paclitaxel-induced changes in affect-like behavior in mice [PDF]

, 2019
The antineoplastic paclitaxel is associated with negative affective outcomes, such as depression, anxiety, and decreased quality of life during treatment and convalescence. With the Baby Boomer population approaching peak cancer age, it is dire that the
Alkhlaif, Yasmin, Damaj, Imad, Meade, Julia, Obeng, Samuel, Selley, Dana E., Toma, Wisam B   +5 more
core   +1 more source

Oxa-Iboga alkaloids lack cardiac risk and disrupt opioid use in animal models

Nature Communications
Ibogaine and its main metabolite noribogaine provide important molecular prototypes for markedly different treatment of substance use disorders and co-morbid mental health illnesses.
Václav Havel, Andrew C. Kruegel, Benjamin Bechand, Scot McIntosh, Leia Stallings, Alana Hodges, Madalee G. Wulf, Mel Nelson, Amanda Hunkele, Michael Ansonoff, John E. Pintar, Christopher Hwu, Rohini S. Ople, Najah Abi-Gerges, Saheem A. Zaidi, Vsevolod Katritch, Mu Yang, Jonathan A. Javitch, Susruta Majumdar, Scott E. Hemby, Dalibor Sames   +20 more
doaj   +1 more source

Conformational characteristics of opioid .KAPPA.-receptor agonist: Crystal structure of (5S, 7S, 8S)-(-)-N-methyl-N-(7-(1-pyrrolidinyl)-1-oxaspiro(4.5)dec-8-yl)benzeneacetamide (U69,593), and conformational comparison with some .KAPPA.-agonists.

, 1990
Mitsunobu Doi, Toshimasa Ishida, Masatoshi Inoue   +2 more
openalex   +2 more sources

Investigating the anti-cocaine effects of novel kappa opioid receptor agonists: Behavioural and cellular actions of Salvinorin A analogues

, 2016
Amy Ewald
openalex   +2 more sources

Effect of the selective kappa-opioid receptor antagonist JDTic on nicotine antinociception, reward, and withdrawal in the mouse

, 2010
Kia J. Jackson, Frank I. Carroll, S. Stevens Negus, M. Imad Damaj   +3 more
openalex   +2 more sources

Lateralized kappa opioid receptor signaling from the amygdala central nucleus promotes stress-induced functional pain

Pain, 2018
Kelsey M Nation, M. De Felice, Pablo Hernandez, D. Dodick, V. Neugebauer, E. Navratilova, F. Porreca   +6 more
semanticscholar   +1 more source

Structure of the Nanobody-Stabilized Active State of the Kappa Opioid Receptor

Cell, 2018
T. Che, S. Majumdar, S. Zaidi, P. Ondachi, J. McCorvy, Sheng Wang, P. Mosier, R. Uprety, Eyal Vardy, B. Krumm, G. Han, Ming-Yue Lee, Ming-Yue Lee, Ming-Yue Lee, E. Pardon, J. Steyaert, Xi Ping Huang, Ryan T. Strachan, A. Tribo, G. Pasternak, F. Carroll, R. Stevens, V. Cherezov, V. Katritch, Daniel Wacker, B. Roth   +25 more
semanticscholar   +1 more source